Searchable abstracts of presentations at key conferences in endocrinology

ea0035p578 | Endocrine tumours and neoplasia | ECE2014

Antiproliferative effects of lanreotide Autogel in patients with enteropancreatic neuroendocrine tumours: results of CLARINET, a large international phase 3 study

Caplin Martyn , Ruszniewski Philippe , Pavel Marianne , Cwikla Jaroslaw , Phan Alexandria , Raderer Markus , Sedlackova Eva , Cadiot Guillaume , Wall Lucy , Rindi Guido , Langley Alison , Blumberg Joelle

Introduction: Data demonstrating antiproliferative effects of somatostatin analogs (SSAs) in enteropancreatic NETs are limited; only one prospective trial so far has shown this for patients with midgut tumors and low hepatic tumor load (HTL). CLARINET is the first large phase 3, randomized, placebo-controlled trial evaluating such effects for the SSA lanreotide in patients with non-functioning enteropancreatic NETs.Methods: Patients who had well/moderate...

ea0070aep69 | Adrenal and Cardiovascular Endocrinology | ECE2020

Pulsatile subcutaneous hydrocortisone replacement in primary adrenal failure, a proof of concept pilot trial

Simunkova Katerina , Øksnes Marianne , Methlie Paal , Jovanovic Nevena , Selemon Gebreslase Nebeyaet , Løvås Kristian , Sverre Husebye Eystein

Background: The pulsatile endogenous cortisol secretion is crucial for ultradian rhythmicity in blood and this rhythmicity triggers pulses of gene signaling in tissues. Disturbances in cortisol pulsatility can lead to cognitive, metabolic and cardiovascular dysfunction, and could explain why patients with primary adrenal insufficiency on conventional glucocorticoid replacement have reduced quality of life, increased mortality and are at risk of cardiovascular complications. Pu...

ea0070aep1073 | Hot topics (including COVID-19) | ECE2020

A randomized-controlled trial of tesomet resulted in significant weight loss in hypopituitary patients with hypothalamic obesity

Huynh Kim , Klose Marianne , Krogsgaard Kim , Drejer Jorgen , Byberg Sarah , Madsbad Sten , Magkos Faidon , Aharaz Abdellatif , Edsberg Berit , Astrup Arne , Feldt-Rasmussen Ulla

Background and objective: Hypothalamic obesity is characterized by rapid and severe weight-gain with increased risk of cardiovascular and metabolic disorders. Currently, there are no approved or effective pharmacological treatments and conventional weight management remain largely ineffective in hypothalamic obesity. This trial investigated safety and efficacy of Tesomet (0.5 mg tesofensine and 50 mg metoprolol) in hypopituitary patients with hypothalamic obesity.<p class=...

ea0032p638 | Male reproduction | ECE2013

Strength training and testosterone treatment have opposing effects on migration inhibitor factor levels in ageing men

Glintborg Dorte , L Christensen Louise , Kvorning Thue , Larsen Rasmus , Brixen Kim , M Hougaard David , Richelsen Bjorn , M Bruun Jens , S Andersen Marianne

Objective: The beneficial effects of testosterone treatment (TT) in men with low normal testosterone levels are debated. Chemokine levels have not previously been evaluated during TT in combination with strength training (ST).Design: A randomized, double-blinded, placebo-controlled study of 6 months TT (gel) in 54 men aged 60–78 years with bioavailable testosterone (BioT) <7.3 nmol/l and waist circumference >94 cm randomized to TT (50–1...

ea0025s2.2 | Novel pathways and treatments in neuroendocrine tumours | SFEBES2011

Integrated genome-wide DNA methylation and mRNA expression analysis of pancreatic NETs

Thirlwell Christina , Schulz Laura , Eymard Marianne , Meyer Tim , Davidson Brian , Teschendorff Andrew , Jiao Yan , Luong Tu-Vinh , Caplin Martyn , Beck Stephan

Integration of genetics and epigenetics has emerged as a powerful approach to study cellular differentiation and tumourigenesis. The study of DNA methylation is of particular importance in cancer as causal involvement has been demonstrated and it is the most stable of all epigenetic modifications, making it a desirable marker for both early detection and treatment of tumours. Hypermethylation of CpG sites in gene promoter regions leads to decreased gene expression, if such a g...

ea0022p617 | Neuroendocrinology and Pituitary (<emphasis role="italic">Generously supported by Novartis</emphasis>) | ECE2010

Epidemiology of craniopharyngioma in Denmark 1985–2004: a 2% increase in incidence rate per year

Husted Nielsen Eigil , Feldt-Rasmussen Ulla , Poulsgaard Lars , Ostergaard Kristensen Lars , Astrup Jens , Otto Jorgensen Jens , Bjerre Per , Andersen Marianne , Andersen Claus , Jorgensen Jesper , Lindholm Jorgen , Laurberg Peter

Background: Craniopharyngioma may be associated with severe morbidity. Few data exist on incidence rate (IR) and possible changes with time. The epidemiology of craniopharyngioma in Denmark has never been evaluated in detail.Objectives: To review the literature on craniopharyngioma incidence and to study the epidemiology of craniopharyngioma in Denmark during a recent 20-year period.Material and methods: Publications including data...

ea0073aep383 | Endocrine-Related Cancer | ECE2021

Paraganglioma of the basis cranii due to somatic mutations ind SDHB and PTEN genes

Main Ailsa Maria , Klose Marianne , Rasmussen Krogh , Loya Anand Chainsukh , Rossing Caroline Maria , Kistorp Thomas , Buch Kaare Fugleholm , Soelling Christine , Poulsgaard Lars , Benndorf Goetz , Feldt-Rasmussen Ulla

Head and neck paragangliomas (HNPGLs) are a type of neuroendocrine tumour. They arise from the sympathetic ganglia and can be either sporadic or due to hereditary syndromes (up to 40%). Most HNPGLs do not produce significant amounts of catecholamines1. Often, HNPGLs are detected in late stages due to compression or infiltration of cranial structures1. We report a case of a paraganglioma of the basis cranii due to somatic variants of SDHB (succinate dehydr...

ea0073aep507 | Pituitary and Neuroendocrinology | ECE2021

Treatment regimens affecting glucose metabolism and gastrointestinal hormones in acromegaly: A descriptive study

Nanna Jørgensen , Erichsen Trine , Klose Marianne , Joergensen Morten , Idorn Thomas , Feldt-Rasmussen Bo , Holst Jens J. , Feldt-Rasmussen Ulla

ContextActive acromegaly is associated with impaired glucose metabolism, which improves upon treatment. Treatment options include surgery, medical therapy with somatostatin analogues (SSA) and Pegvisomant (PEG) and in few cases irradiation.ObjectiveTo describe the differential effect of various treatment regimens on the secretion of glucose, insulin, glucagon, glucagon-like peptide-1 (GLP1), and glucose-depen...

ea0092op-04-04 | Oral Session 4: Young Investigators / Clinical and Translational | ETA2023

The association between maternal thyroid function and language acquisition in offspring aged 12 to 37 months: an odense child cohort study

Ryom Riis Kamilla , Joop Bonnema Steen , Fenger Dreyer Anja , Kold Jensen Tina , Glintborg Dorte , Bilenberg Niels , Bleses Dorthe , Trecca Fabio , Andersen Marianne

Introduction: Maternal thyroid function in early pregnancy is crucial for fetal neural development. Early offspring language acquisition is an important indicator of fetal neural development and a predictor of future cognitive development. We aimed to investigate how the mother’s thyroid function and the presence of thyroid autoimmunity in early pregnancy are associated with offspring’s language acquisition at the age of 12-37 months.Methods: T...

ea0099p263 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Risk of type 2 diabetes in 99,892 nordic women with polycystic ovary syndrome and 446,055 controls: national cohort study from Denmark, Finland and Sweden

Glintborg Dorte , Ollila Meri-Maija , Moller Jens-Jakob , Pesonen Paula , Persson Sofia , Elenis Evangelia , Rubin Katrine , Gissler Mika , Andersen Marianne , Sundstrom-Poromaa Inger , Piltonen Terhi

Background: The risk of type 2 diabetes (T2D) in PCOS is associated with BMI, but prospective data regarding risk of T2D in PCOS are limited. We investigated prospective risk of T2D in Nordic women with PCOS compared to controls.Methods: National register-based study in women with PCOS and age-matched controls originating from Denmark (PCOS Denmark, (n=27,016, controls, (n=133,994), Finland (PCOS Finland, (n=20,467, controls, (...